Thus, we speculate that the interaction of CCR6 and CCL18 might be pivotal for the progress of IPF, whereas in fibrosis, due to sarcoidosis or HP, these processes are obviously driven by other factors. The gene discussed is CCR6; the disease is hypersensitivity pneumonitis.